logo
How ‘Inflammaging' Drives Cancer—and Points to New Treatments

How ‘Inflammaging' Drives Cancer—and Points to New Treatments

People are more likely to get cancer as they age. Dr. Miriam Merad has an unconventional idea of how that might be reversed: using allergy drugs and other seemingly unlikely medications to damp a condition known as 'inflammaging.'
The immunologist and oncologist has spent years examining malignant tumors to learn why people over age 50 account for nine in 10 cancer diagnoses in the U.S. She and her research team at the Icahn School of Medicine at Mount Sinai in New York City have homed in on an answer: the aging immune system. Their studies of individual immune cells in human lung tumors, as well as in old mice, have revealed how chronic, or pathogenic, inflammation in older people—dubbed inflammaging—interferes with the immune system and fuels cancer growth.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

Yahoo

time4 minutes ago

  • Yahoo

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Rancho Palos Verdes to ban new construction in landslide zone
Rancho Palos Verdes to ban new construction in landslide zone

Yahoo

time4 minutes ago

  • Yahoo

Rancho Palos Verdes to ban new construction in landslide zone

Rancho Palos Verdes has moved forward with plans to permanently ban new construction across 715 acres of land that has been plagued by dramatic and destructive landslide movement over the last two years. City councilmembers on Tuesday night voted unanimously to prohibit almost all new development, including home additions, throughout the landslide zone, which encompasses approximately 400 homes and 130 vacant, privately owned lots across three neighborhoods. The change to the city's building code would, however, permit repairs, restoration efforts and even the replacement of existing homes, so long as the updates don't exceed the original, damaged home's square footage. It also provides for a way for land owners to apply for an exception. Tuesday's vote is the first step to make permanent a moratorium that had been in place since land movement dramatically accelerated almost two years ago. The change will only take place after a final approval later this month. But with overwhelming support from city leaders, it appears likely to go into effect by the end of September. Read more: Is it finally time to ban new homes in the Rancho Palos Verdes' landslide zone? Despite well-documented issues from the landslide since October 2023, the move faces opposition, especially from homeowners who live in areas that have recently stabilized. Criticism and concern have also come from landowners sitting on undeveloped lots, or from homeowners who were recently included in the designated landslide zone. That designation came after geologists confirmed that the recent movement had expanded past historic boundaries. Many other homeowners, however, said they were in support of the ban. City officials said the changes were about safety, and pointed to the last two years of unprecedented landslide movement. The movement has fractured homes, warped several roads and severed shut off electricity and gas service for hundreds. Though the area has long been known for recurring issues from a complex of ancient landslides that reemerged in the 1950s, the rate and scale of the movement since October 2023 has never before been recorded. 'We're very sensitive about the land and the folks that are now included in this [prohibition] zone," Mayor Pro Tem Paul Seo said at Tuesday's city council meeting. "... But what it comes down to is public safety and well-being for the people on that land.' The city had enacted a similar ban on development in the landslide zone decades ago, but it was repeatedly weakened by lawsuits and exceptions. City leaders on Tuesday said that some of the homes damaged in the recent movement were among a group that fought the initial construction ban, and won approval to build in the landslide zone through a lawsuit in the early 2000s. At least five recently applied for federal buyouts, city officials said. Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week. This story originally appeared in Los Angeles Times.

Trump met Citigroup, BofA CEOs to discuss Fannie and Freddie, sources say
Trump met Citigroup, BofA CEOs to discuss Fannie and Freddie, sources say

Yahoo

time4 minutes ago

  • Yahoo

Trump met Citigroup, BofA CEOs to discuss Fannie and Freddie, sources say

NEW YORK (Reuters) -U.S. President Donald Trump met Citigroup CEO Jane Fraser at the White House on Wednesday to discuss the administration's plans for Fannie Mae and Freddie Mac, according to a source familiar with the situation. Trump also met with Bank of America CEO Brian Moynihan and his team to discuss Fannie and Freddie, a separate source said. The administration had previously said it plans to take the firms public, but will keep oversight and guarantees in the mortgage market. The White House declined to comment on private meetings.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store